Skip to content

Visco-Circumferential-Suture-Trabeculotomy Versus Trabeculotomy

Surgical Outcomes of Visco-Circumferential-Suture-Trabeculotomy in Primary Congenital Glaucoma: A 3-year Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04683289
Enrollment
51
Registered
2020-12-24
Start date
2015-01-01
Completion date
2020-09-01
Last updated
2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Congenital Glaucoma

Brief summary

comparing outcomes of Visco-Circumferential-Suture-Trabeculotomy in primary congenital glaucoma to trabeculotomy

Detailed description

prospective randomized interventional study conducted on infants below the age of 2 years with PCG attending the outpatient clinic of Mansoura Ophthalmic Center of Mansoura University were recruited to compare the long-term surgical outcomes of this proposed technique (VCST) and rigid probe VT in patients with PCG.

Interventions

PROCEDUREtrabeculotomy

performing partial unroofing of the SC and viscoelastic injection into the 2 ostia of the canal. This was followed by connecting the scalemm canal to the anterior chamber

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 2 Years
Healthy volunteers
No

Inclusion criteria

* infants below the age of 2 years with PCG

Exclusion criteria

* patients older than 2 years on presentation * eyes with previous surgery * eyes with secondary glaucoma * eyes diagnosed as anterior segment dysgenesis syndrome

Design outcomes

Primary

MeasureTime frameDescription
IOP36 monthsintraocular pressure measuring

Secondary

MeasureTime frameDescription
complications36 months monthsvisual devastating complications

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026